Kamada (KMDA) Operating Margin (2012 - 2026)
Kamada's (KMDA) quarterly Operating Margin came in at 15.37% in Q1 2026, down 234.0% YoY from 11.47% in Q1 2025, and down 18.57% on a QoQ basis from 18.88% in Q4 2025.
Kamada (KMDA) Operating Margin (2012 - 2026) Analysis & Trends
Kamada (KMDA) has 15 years of Operating Margin data on file, last reported at 15.37% in Q1 2026.
- Quarterly Operating Margin fell 234.0% year-over-year to 15.37% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 42.23% (up 4215.0% YoY) and the FY2025 annual result came in at 14.54%, up 208.0% from the prior year.
- Operating Margin declined to 15.37% in Q1 2026, from 18.88% in the prior quarter.
- In the past five years, Operating Margin ranged from a high of 11514.74% in Q3 2023 to a low of 9.72% in Q2 2022.
- A 5-year average of 689.27% and a median of 10.7% in 2024 frame the typical range for Operating Margin.
- Annual changes were most pronounced in 2023 — Operating Margin soared 1150678 bps — and 2024, when it slumped 1149127 bps.
- Tracing KMDA's Operating Margin over 5 years: stood at 8.84% in 2022, then decreased by 14 bps to 7.62% in 2023, then jumped by 224 bps to 24.73% in 2024, then decreased by 24 bps to 18.88% in 2025, then declined by 19 bps to 15.37% in 2026.
- The last three Operating Margin figures came in at 15.37% (Q1 2026), 18.88% (Q4 2025), and 26.21% (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | -5.58% |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 33.91% |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 16.51% |
| 5 | United Therapeutics | 22.19 Bn | 19.53 Bn | 683.80 Mn | 42.23% |
| 6 | Viatris | 18.68 Bn | 17.79 Bn | 1.46 Bn | 0.17% |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 15.80% |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | 18.13% |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Kamada | 466.36 Mn | 436.89 Mn | 22.47 Mn | 17.32% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 17.32% |
| Mar 31, 2026 | 15.37% |
| Dec 31, 2025 | 18.88% |
| Sep 30, 2025 | 26.21% |
| Jun 30, 2025 | 42.30% |
| Mar 31, 2025 | 17.71% |
| Dec 31, 2024 | 24.73% |
| Sep 30, 2024 | 23.47% |
| Jun 30, 2024 | 0.01% |
| Mar 31, 2024 | 10.70% |
| Dec 31, 2023 | 7.62% |
| Sep 30, 2023 | 11,514.74% |
| Jun 30, 2023 | 7.03% |
| Mar 31, 2023 | 0.94% |
| Dec 31, 2022 | 8.84% |
| Sep 30, 2022 | 7.95% |
| Jun 30, 2022 | -9.72% |
| Mar 31, 2022 | 0.88% |
| Dec 31, 2021 | -10.49% |
| Sep 30, 2021 | -3.49% |